For citations:
Khachaturyan E.A., Antonova T.G., Stativko O.A., Pokataev I.A. Lenvatinib in combination with pembrolizumab as first-line therapy for advanced endometrial cancer: clinical case. Tumors of female reproductive system. 2025;21(1):142-146. (In Russ.) https://doi.org/10.17650/1994-4098-2025-21-1-142-146
Email this article 